Medpace Holdings Inc vs Omega Healthcare Investors Inc. Common Stock — how do they compare? Medpace Holdings Inc trades at $616.98 (market cap $17.21B), while Omega Healthcare Investors Inc. Common Stock trades at $45.37 (market cap $13.66B). The key difference: Medpace Holdings Inc is the larger of the two by market cap, and Omega Healthcare Investors Inc. Common Stock pays a 6.03% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Omega Healthcare Investors Inc. Common Stock for 0 Days on average.
| MEDP | OHI | |
|---|---|---|
Market Cap | $17.21B | $13.66B |
Volume | 311,245 | 1,351,548 |
Sector | Health | Real Estate |
52-Week High | $630.19 | $51.72 |
52-Week Low | $393.42 | $39.53 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | $16.83B | $17.65B |
Dividend Yield | — | 6.03% |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $609.89, down 1.64% today, with a bullish technical signal and strong support near $606. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue grew to $2.53B in 2025, with a net income margin of 17.67%. Recent news highlights CEO stock sales and institutional position adjustments.
Outlook remains positive with a consensus price target of $620.44, offering modest upside. Key risks include high valuation multiples and insider selling. Earnings growth and sector demand are primary catalysts, but investor caution is warranted given elevated P/E and P/B ratios.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Omega Healthcare Investors Inc. is a real estate investment trust that owns skilled nursing and assisted living facilities, which it leases to healthcare operators under long-term, primarily triple-net lease structures. It partners with healthcare providers across US and UK markets.
Read more on OHI →